Dr. Divgi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1417 Robinhood Road
Jenkintown, PA 19046Phone+1 212-837-1913
Education & Training
Memorial Sloan Kettering Cancer CenterImmunology, 1987 - 1989- Memorial Sloan Kettering Cancer CenterResidency, Nuclear Medicine, 1985 - 1987
St. John's Medical CollegeClass of 1976
Certifications & Licensure
NY State Medical License 1991 - 2026
PA State Medical License Active through 2012- American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- New York Magazine: Top Doctors Castle Connolly, 2014
- Top Doctors: New York Metro Area Castle Connolly, 2014
Clinical Trials
- Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer Start of enrollment: 1998 Nov 17
- Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer Start of enrollment: 2000 Aug 02
- Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer Start of enrollment: 2003 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsAntibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular modelChunsheng Li, Ann-Marie Chacko, Jia Hu, Kosei Hasegawa, Jennifer Swails
Cancer Biology & Therapy. 2014-02-19 - 157 citationsSequential Cytarabine and α-Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid LeukemiaTodd L. Rosenblat, Michael R. McDevitt, Deborah Mulford, Neeta Pandit-Taskar, Chaitanya R. Divgi
Clinical Cancer Research. 2010-11-01 - 191 citationsIntraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab′)2—A Phase I StudyHåkan Andersson, Elin Cederkrantz, Tom Bäck, Chaitanya R. Divgi, Jörgen Elgqvist
Journal of Nuclear Medicine. 2009-07-01
Press Mentions
- Bicara Therapeutics Launches with Deep Pipeline of First-in-Class Dual Action Biologics for Cancer ImmunotherapyMarch 15th, 2021
PET Imaging Identifies Aggressive Kidney Cancers That Require SurgeryMarch 9th, 2007
Grant Support
- Novel Antigen-Binding Constructs In Colorectal CancerNational Cancer Institute2008–2009
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
